Tizanidine Tablet
Product Images NDC 80425-0454

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 80425-0454). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tizanidine 4mg #30 (Tizanidine 4mg 80425 0454 01)

This is information about a medication called Tizanidine 4mg tablet, which comes in a package of 30 tablets. It is a generic version of Zanaflex. The NDC number is 80425-0454-01. The source NDC is 72578-0097-21. The lot number is X000 and it expires on 3/31/2026. The medication is likely from a pharmacy named ST VionA PHARMACEY.*

FDA Label Image

Tizanidine 4mg #60 (Tizanidine 4mg 80425 0454 02)

Description: This is a pack of Tizanidine 4mg tablets totalling 60 units, meant for oral consumption. The tablets are advised to be stored at a temperature ranging between 20°C to 25°C (68°F to 77°F). The medication is a generic version of Zanaflex and has an expiration date of 3/31/2026. The item was packed by "g" and is sourced from Advancedrx. The lot number is marked as "XXXXXX" and the packaging is from Viona Pharmaceuticals.*

FDA Label Image

Tizanidine 4mg #90 (Tizanidine 4mg 80425 0454 03)

Store the Tizanidine 3mg tablets at a temperature between 20-25°C (68-77°F). This pack contains #90 tablets, equivalent to Zanaflex. The lot number is XXKXXX with an expiration date of 3/31/2026. The manufacturer is Viona Pharmacy.*

FDA Label Image

Tizanidine 4mg #120 (Tizanidine 4mg 80425 0454 04)

This is a pack of 120 Tizanidine 2 mg tablets similar to Zanaflex, to be stored between 20-25°C. It has a NDC number of 80425-0454-04 and an expiration date of 3/31/2026. The packaging is done by Viona Pharmaceuticals.*

FDA Label Image

Figure (C1813e2d 81a1 4db6 80a3 12c265d1e8f5 01)

FDA Label Image

Figure (C1813e2d 81a1 4db6 80a3 12c265d1e8f5 02)

FDA Label Image

Figure (C1813e2d 81a1 4db6 80a3 12c265d1e8f5 03)

This text mentions the Ashworth Score improvement based on different dosages of tizanidine and a placebo over time post-dose. It seems to be a comparison study evaluating the effects of medication on the Ashworth Score.*

FDA Label Image

Figure (C1813e2d 81a1 4db6 80a3 12c265d1e8f5 04)

This text discusses an improvement in the Ashworth Score using Tizanidine at a mean dose of 26.8 mg. It mentions the progression of the study from titration to maintenance to the study endpoint at week 7, using the Last Observation Carried Forward method.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.